Many sight loss patients encounter unproven or bogus eye treatments
An international study of almost 1,000 people living with sight loss, led by University College London (UCL) researchers, found that nearly one in five reported receiving or encountering eye treatments they believed to be 'bogus'.
Read original article on The Medical News →Related news
-
European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease
United Kingdom
-
Recruitment begins for 600 future medical researchers
United Kingdom
-
Virtual reality and music may help lower blood pressure during emergencies
United Kingdom
-
Drone-delivered AEDs could reduce defibrillation delays after cardiac arrest
United Kingdom
-
MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026
United Kingdom
-
UCLA researchers present new radiation advances at ASTRO 2026
United Kingdom
-
AI-based model predicts glioblastoma recurrence to guide targeted treatment
United Kingdom
-
AI-generated video summaries can reshape people's memories of events
United Kingdom